ANG Lifesciences India Limited (BOM:540694)
India · Delayed Price · Currency is INR 24.03
-1.12 (-4.45%)
At close: Jan 19, 2026
ANG Lifesciences India Company Description
ANG Lifesciences India Limited engages in manufacturing and sale of finished pharmaceutical formulations in India and internationally.
Its product portfolio comprises therapeutics categories, such as antibiotics, antiviral, antimalarial, antiulcer, carbapenem, corticosteroid, penicillin, and beta lactamase inhibitor.
The company offers its finished pharmaceutical formulations in a dosage form of sterile dry powder injection vials, liquid injection vials, ampoules, PFS, hard gelatin capsules, soft gelatin capsules, dry syrups, liquid syrups and suspension, and lotions.
ANG Lifesciences India Limited was incorporated in 2006 and is based in Amritsar, India.
ANG Lifesciences India Limited
| Country | India |
| Founded | 2006 |
| Industry | Pharmaceutical Preparations |
| Employees | 412 |
| CEO | Rajesh Gupta |
Contact Details
Address: Darbara Complex, SCO 113 Amritsar, 143001 India | |
| Phone | 91 18 3513 3455 |
| Website | anglifesciences.com |
Stock Details
| Ticker Symbol | 540694 |
| Exchange | Bombay Stock Exchange |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Rajesh Gupta | Chief Executive Officer |
| Saruchi Gupta | Chief Financial Officer |